About us

**Barkat Pharmaceutical Group**, with over 20 subsidiary companies, was established in 2010 (1389 AH) under the name “Tadbir Advanced Pharmaceutical Technologies Company,” based on analysis and future planning of the pharmaceutical industry in Iran, aiming to meet the needs of society. As a knowledge-based economic entity, the group has chosen to focus on health products. Our operations are based on progressing towards realizing the vision of Iran 2025 and aligning with the National Comprehensive Scientific Plan, fulfilling our social responsibilities, and valuing human principles. One of the group’s goals is to promote social justice and increase access to new health products for the underprivileged by producing medications at lower costs. Barkat Pharmaceutical Group’s broad strategy is to enter advanced pharmaceutical fields, including biotechnology, drug delivery technologies such as nanotechnology, slow-release drugs, and new health technology areas. It also aims to develop the cellular and molecular industry, including cell therapy, gene therapy, immunotherapy, and tissue engineering technologies.